3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
2
Sarcoma
1
Breast
1
Conditions
Breast Neoplasms
379
Triple Negative Breast Neoplasms
61
Ovarian Neoplasms
46
Prostatic Neoplasms
35
Colorectal Neoplasms
35
Neoplasms
28
Carcinoma, Non-Small-Cell Lung
27
Endometrial Neoplasms
24
Lung Neoplasms
22
Neoplasm Metastasis
21
Uterine Cervical Neoplasms
19
Melanoma
18
Stomach Neoplasms
17
Pancreatic Neoplasms
16
Squamous Cell Carcinoma of Head and Neck
15
Carcinoma, Renal Cell
14
Urinary Bladder Neoplasms
13
Sarcoma
12
Head and Neck Neoplasms
12
Esophageal Neoplasms
11
Colonic Neoplasms
10
Advanced Breast Cancer
9
Small Cell Lung Carcinoma
8
Carcinoma, Transitional Cell
8
Anatomic Stage I Breast Cancer AJCC v8
8
Liver Neoplasms
7
Kidney Neoplasms
7
Cholangiocarcinoma
7
Carcinoma, Hepatocellular
6
Brain Neoplasms
6
Interventions
elacestrant
1
abemaciclib
1
RAD1901
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Diseases
×
Breast
×
30 days
×
Clear all
NCT05386108
2026-06-04
ELECTRA
Stemline Therapeutics, Inc.
Phase 1/2
Recruiting
73 enrolled